{"id":"W2049141040","doi":"10.3324/haematol.2013.100818","title":"R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes","year":2014,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"F. Hoffmann-La Roche","keywords":"Medicine; CHOP; Rituximab; Internal medicine; Vincristine; Gastroenterology; Hazard ratio; Diffuse large B-cell lymphoma; Bevacizumab; Lymphoma; Surgery; Confidence interval; Oncology; Cyclophosphamide; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002944671,0.001220303,0.002936941,0.0005900835,0.0003113375,0.001567831,0.0005245439,0.001265814,0.002981778],"category_scores_gemma":[0.002740651,0.0003892489,0.005065047,0.0005956332,0.0004316508,0.001141473,0.0005826465,0.00180983,0.0003867156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006853643,"about_ca_system_score_gemma":0.0007880706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004731056,"about_ca_topic_score_gemma":0.001246727,"domain_scores_codex":[0.9983585,0.0008613256,0.0001583156,0.0002371715,0.000136968,0.0002476831],"domain_scores_gemma":[0.9981699,0.000693629,0.0005452642,0.0000981125,0.0001276101,0.000365533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9216317,0.002331415,0.01262347,0.002635223,0.01360711,0.0001657019,0.0000675262,0.0009760272,0.001499467,0.000183188,0.001377938,0.04290123],"study_design_scores_gemma":[0.6262954,0.2187835,0.1080574,0.0008723734,0.03138809,0.0004957752,0.0001426901,0.002210739,0.002400229,0.001098252,0.008150175,0.0001053831],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9560257,0.03194323,0.00109225,0.0007045573,0.0004562674,0.001543915,0.003127415,0.00008845965,0.005018295],"genre_scores_gemma":[0.9878834,0.004533418,0.0006416785,0.0008674532,0.0006188952,0.001361417,0.002564545,0.00002406562,0.001505131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002981778,"threshold_uncertainty_score":0.01557314,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01415383399888104,"score_gpt":0.2506356434290047,"score_spread":0.2364818094301237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}